SCHEMBL12847300

SCHEMBL12847300

Cc1nc2ccc(N(C)c3ccc(O)cc3)cc2c(=O)n1C(c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GFER P55789 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ LMNA P02545 2/20 0.36
▸ IDO1 P14902 1/20 0.35
▸ TDO2 P48775 1/20 0.35
▸ IDO2 Q6ZQW0 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ POLB P06746 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MCL1 Q07820 1/20 0.34
▸ HDAC1 Q13547 2/20 0.34
▸ HDAC8 Q9BY41 2/20 0.34
▸ HDAC6 Q9UBN7 2/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ HDAC10 Q969S8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12788546 0.93 ALDH1A1 (0.37) KDM4ELMNAIDO1TDO2IDO2
SCHEMBL12788643 0.91 ALDH1A1 (0.37) KDM4ELMNAIDO1TDO2IDO2
SCHEMBL12846989 0.89 ALDH1A1 (0.35) KDM4EHSD17B10LMNAIDO1TDO2
SCHEMBL12788865 0.89 KDM4C (0.36) KDM4ELMNAIDO1TDO2IDO2
SCHEMBL12788595 0.89 POLB (0.43) KDM4EGAAHSD17B10IDO1TDO2
SCHEMBL12788639 0.89 KDM4E (0.42) KDM4EHSD17B10LMNAALDH1A1POLB
SCHEMBL12788888 0.88 LMNA (0.41) KDM4EHSD17B10LMNAALDH1A1MAPK1
SCHEMBL12788806 0.88 POLB (0.42) KDM4EGAAHSD17B10IDO1TDO2
SCHEMBL12788621 0.88 KDM4C (0.38) LMNAIDO1TDO2IDO2ALDH1A1
SCHEMBL12846987 0.88 RAB9A (0.39) KDM4EGAAHSD17B10LMNAIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065671-A1 BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS MERCK SHARP & DOHME CORP. 2011-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065671-A1 BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS GPR119, GPR39, GPR65 GFER 3565/4885KDM4E 3477/4885GAA 2634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback